Page last updated: 2024-11-02

oxyphenbutazone and Leukemia

oxyphenbutazone has been researched along with Leukemia in 8 studies

Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19908 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SJOBERG, S1
PERERS, D4
Chaplin, S1
Sjöberg, SG3
Råde, L1
Engstedt, L1
Nordén, A1
Heimann, P1
Haeger, K1

Reviews

1 review available for oxyphenbutazone and Leukemia

ArticleYear
Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part II.
    Adverse drug reactions and acute poisoning reviews, 1986,Autumn, Volume: 5, Issue:3

    Topics: Anemia, Aplastic; Bone Marrow; Chloramphenicol; Dose-Response Relationship, Drug; Erythropoiesis; Hu

1986

Other Studies

7 other studies available for oxyphenbutazone and Leukemia

ArticleYear
LEUKEMIA AFTER OXYPHENYLBUTAZONE.
    Lancet (London, England), 1965, Aug-28, Volume: 2, Issue:7409

    Topics: Drug Therapy; Humans; Leukemia; Oxyphenbutazone; Toxicology

1965
[Acute leukemia, leukemoid reaction and leukocytosis after their treatment with oxyphenbutazone].
    Lakartidningen, 1966, Jan-05, Volume: 63, Issue:1

    Topics: Humans; Leukemia; Leukemoid Reaction; Leukocytosis; Oxyphenbutazone

1966
[Oxyphenbutazone and leukemia--statistical aspects].
    Lakartidningen, 1966, Feb-23, Volume: 63, Issue:8

    Topics: Humans; Leukemia; Oxyphenbutazone; Sweden

1966
[Oxyphenbutazone and leukemia].
    Lakartidningen, 1966, May-04, Volume: 63, Issue:18

    Topics: Humans; Leukemia; Oxyphenbutazone

1966
[Tanderil, leukemia and statistics].
    Lakartidningen, 1966, May-11, Volume: 63, Issue:19

    Topics: Humans; Leukemia; Oxyphenbutazone; Sweden

1966
[Oxyphenylbutazone and leukemia].
    Lakartidningen, 1966, Feb-02, Volume: 63, Issue:5

    Topics: Humans; Leukemia; Oxyphenbutazone

1966
[The connection between Tandearil and leukemia].
    Svensk farmaceutisk tidskrift, 1966, Mar-10, Volume: 70, Issue:7

    Topics: Leukemia; Oxyphenbutazone

1966